KROS·492327101·US·equity·Healthcare - Biotechnology-Activist
KROS (KEROS THERAPEUTICS INC) is held by 87 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($26.6M), Qube Research & Technologies Ltd ($8M), JACOBS LEVY EQUITY MANAGEMENT, INC ($7.8M). Net institutional sentiment: Mixed.
See how KROS's score breaks down across 4 SEC sources
Showing 1-20 of 97
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer